Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
312.73B
Market cap312.73B
Price-Earnings ratio
36.16
Price-Earnings ratio36.16
Dividend yield
2.61%
Dividend yield2.61%
Average volume
13.65M
Average volume13.65M
High today
$128.50
High today$128.50
Low today
$125.07
Low today$125.07
Open price
$127.99
Open price$127.99
Volume
2.81M
Volume2.81M
52 Week high
$130.29
52 Week high$130.29
52 Week low
$76.66
52 Week low$76.66

Stock Snapshot

As of today, Merck(MRK) shares are valued at $126.62. The company's market cap stands at 312.73B, with a P/E ratio of 36.16 and a dividend yield of 2.61%.

On 2026-07-01, Merck(MRK) stock traded between a low of $125.07 and a high of $128.50. Shares are currently priced at $126.62, which is +1.2% above the low and -1.5% below the high.

Merck(MRK) shares are trading with a volume of 2.81M, against a daily average of 13.65M.

During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $130.29 at its peak.

During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $130.29 at its peak.

MRK News

TipRanks 1d
House committee opens probe into Merck, AbbVie China drug trials, Reuters says

A bipartisan group of U.S. lawmakers has opened national security investigations into whether drugmakers Merck (MRK) and AbbVie (ABBV) have been involved in cli...

Benzinga 1d
Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report

The lawmakers are seeking details about the companies’ clinical trial operations, data protection measures and due diligence practices at research sites across...

Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report
Investing.com 1d
Scotiabank raises Merck stock price target to $155 on pipeline - Investing.com

...

Scotiabank raises Merck stock price target to $155 on pipeline - Investing.com

Analyst ratings

70%

of 30 ratings
Buy
70%
Hold
26.7%
Sell
3.3%

More MRK News

Simply Wall St 1d
Broadcom Stock And Two AI Automation Picks Backed By Cash Flow

Global inflation trends, uneven central bank policies, and shifting energy costs are creating a market where headline noise can obscure quieter opportunities. W...

Broadcom Stock And Two AI Automation Picks Backed By Cash Flow
Nasdaq 4d
The Smartest Dividend Stocks to Buy With $5,000 Right Now

When a company earns a profit, it can pay a portion to shareholders as dividends. That's a nice reward for shareholders, providing regular income. However, it's...

The Smartest Dividend Stocks to Buy With $5,000 Right Now
Benzinga 5d
Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’

Qualcomm outlined the acceleration of its diversification strategy at its 2026 Investor Day on June 24. In connection with the event, the semiconductor company...

Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’
Simply Wall St 6d
Merck Agrees $11.3 Billion Bio Techne Deal To Grow Life Sciences Reach

Merck KGaA, traded in the U.S. via NYSE:MRK, agreed to acquire Bio-Techne Corporation in an US$11.3b transaction. The deal is structured to expand Merck KGaA’s...

Merck Agrees $11.3 Billion Bio Techne Deal To Grow Life Sciences Reach
TipRanks 6d
Merck says FDA approves Keytruda and Keytruda Qlex in combo with Trodelvy

Merck (MRK) announced the U.S. FDA approved Keytruda and Keytruda Qlex, each in combination with Trodelvy, Gilead’s (GILD) Trop-2-directed antibody-drug conjuga...

The Wall Street Journal 6d
Germany’s Merck to Buy Bio-Techne for $11 Billion

Merck said the deal for Bio-Techne will be funded through a combination of existing cash and new debt. Ralph Orlowski / REUTERS Germany’s Merck MRK 0.25 %incre...

Germany’s Merck to Buy Bio-Techne for $11 Billion

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.